Registry of patients undergoing coronary interventions at Hanyang University hospitals
Official title: HanYang University Medical Center (HYUMC) PCI Registry
Run by Hanyang University Seoul Hospital · NCT05935397 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is collecting information from patients with coronary artery disease who have had heart procedures to see how they do over time and what factors might affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Hanyang University Seoul Hospital Academic / other |
| Locations | 3 sites (Guri and 2 other locations) |
| Trial ID | NCT05935397 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with coronary artery disease who have undergone PCI with drug-eluting stents at the participating hospitals.
✕Probably not a fit
Patients who have had multiple hospital admissions, died during hospitalization, or were treated with first-generation drug-eluting stents may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The HYUMC registry is a two-center observational registry that collects data on patients with coronary artery disease who have undergone percutaneous coronary intervention (PCI) at Hanyang University Seoul and Guri Hospitals since January 2012. It aims to evaluate long-term clinical outcomes and identify predictors of adverse outcomes following PCI. Researchers gather demographic, laboratory, echocardiographic, and angiographic data, along with patient questionnaires, to assess the impact of these factors on patient health over time.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of long-term outcomes for patients with coronary artery disease, leading to improved treatment strategies.
How similar studies have gone: Other observational registries have shown success in identifying long-term outcomes in similar patient populations, suggesting that this approach is validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea. Exclusion Criteria: * second or subsequent hospitalization records of patients with multiple admissions * patients who died during index hospitalization * patients who treated with first-generation drug eluting stent * patients with an outpatient follow-up record of less than 6 months * patients with insufficient medical records.
Where it's running
-
Hanyang University Guri Hospital
Guri, Korea, Republic of Recruiting -
Hanyang University Seoul Hospital
Seoul, Korea, Republic of Recruiting -
Young-Hyo Lim
Seoul, Korea, Republic of Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical features, treatments, and outcomes in inflammation-associated non-rapidly-progressive coronary artery disease
This study will see how current treatments, inflammation markers, and patient characteristics relate to outcomes in people with inflammation-associated non-rapidly-progressive coronary artery disease (INR-CAD).
-
Evaluating vessel imaging for coronary artery disease
This study is testing if a special imaging technique can help doctors better understand plaque in the arteries of people with heart issues and see how it relates to blood flow.
-
IRIS Coroflex NEO stent registry
This project tests whether Coroflex ISAR NEO drug-eluting stents are safe and work well for adults having percutaneous coronary intervention for coronary artery disease.
-
Investigating characteristics of a special type of coronary artery disease
This study is trying to understand the unique features of a fast-progressing type of coronary artery disease by comparing patients with this condition to those with a more common form of the disease.
-
Evaluating comprehensive treatment for rapidly-progressive coronary artery disease
This study is testing a new treatment plan for people with rapidly-progressive coronary artery disease that includes medication and procedures to see if it helps them feel better and manage their condition.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.